Norwich is a biotechnology enterprise focusing on technical research and development and product development of functional proteins such as enzymes, antigens, antibodies, and polymer organic materials. Relying on the independently established key common technology platforms, it has successively entered the business fields of life sciences, in vitro diagnosis, biomedicine, etc. It is one of the few R&D and innovative enterprises in China that have both independent and controllable upstream technology development capabilities and terminal product production capabilities, and is committed to Intelligent manufacturing of "biochips" continues to inject new vitality into the development of the biotechnology industry.

Innovation and R&D capabilities and talent reserves

Novizan has always adhered to innovation and is committed to breakthroughs. It insists on starting research and development from the source of technology. Relying on independent core technologies, it builds a key common technology platform that can quickly, efficiently and on a large scale. It has more than 600 genes. It has key raw materials such as engineering recombinases and more than 2,500 high-performance antigens and monoclonal antibodies. It has more than 2,000 terminal products and can be widely used in scientific research, high-throughput sequencing, in vitro diagnosis, medicine and vaccine research and development, and animal quarantine.

A strong talent team is the support of R&D strength. Norwich has a R&D innovation team of nearly 700 people, composed of composite R&D personnel in various fields such as molecular biology, enzymatics, immunology, bioinformatics, organic chemistry and materials science, of which 67% of R&D personnel have Master's degree or above.

Master the core technology of raw materials and gather downstream industry advantages

Since its establishment, Novozan has always adhered to the business philosophy of R&D as the core, relying on independent core technologies, constantly updated and iterated technology and upgraded, and opened up new business areas. Through years of hard work, Novozan has achieved technical achievements in the field of biomedicine. It has successfully launched biological reagents including high-throughput sequencing library construction series, PCR series, qPCR series, molecular cloning series, reverse transcription series, Bio-assay and other series, as well as cardiovascular and cerebrovascular, inflammatory infection, eugenics and gastric system. 9 series of POCT diagnostic reagents including function and nervous system, and have formed a variety of customer groups including scientific research institutions, high-throughput sequencing service enterprises, molecular diagnostic reagent manufacturers, pharmaceutical enterprises, CRO enterprises, hospitals and other medical institutions. Customer portfolio.

Don't forget your mission and fulfill your responsibilities

While expanding and deepening the product and technology chain, Novozan has always adhered to the mission of "technology to achieve healthy life", constantly developing new technologies and providing high-quality products and professional services around the "discovery-diagnosis-prevention-treatment" of diseases. , create value for customers.

Norwich is based on the strugglers and provides employees with a broad development platform, attracting outstanding talents from all over the country and even the world to join, and promoting the overall development and improvement of China's biomedical technology industry. Novizan actively participates in the construction of public health, uses technology to help national biosecurity construction, and helps mankind overcome major infectious diseases, tumors, and autoimmune diseases!